Mumbai based Alkem Laboratories launches Ibuprofen, Famotidine tablets in US market

Alkem Laboratories (Alkem) today announced the launch of Ibuprofen and Famotidine Tablets (800 mg/26.6 mg) in the United States, following an approval from the United States Food and Drug Administration (US FDA).

Ibuprofen and Famotidine Tablets is AB-rated generic therapeutic equivalent version of Horizon Medicines LLC's Duexis Tablets, 800 mg/26.6 mg.

This is the first generic approval of Duexis Tablets, 800 mg/26.6 mg by the US FDA. The launch is a subject of ongoing litigation.